AGY vs H5P: Side-by-Side Comparison
Compare Allergy Therapeutics (AGY) and Hikma Pharmaceuticals PLC (H5P) side by side: market cap GBX 44.96B vs EUR 3.75B. Financials, growth and model signals on Bullrun.
| Metric | AGY | H5P |
|---|---|---|
| Company | Allergy Therapeutics | Hikma Pharmaceuticals PLC |
| Country / Exchange | United Kingdom · LSE | United Kingdom · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | GBX 44.96B | EUR 3.75B |
| P/E ratio | — | 11.2 |
| Dividend yield | — | 4.05% |
| Valuation model | — | — |
| Revenue (FY2025) | GBP 55.04M | EUR 3.35B |
| Revenue growth YoY | -0.3% | +7.1% |
| Net income | GBP -40.13M | EUR 402.00M |
| Gross margin | 53.2% | 43.0% |
| Diluted EPS | -0.01 | 1.81 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.